Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- ELF.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
e.l.f. Beauty (ELF) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
NEUTRAL$104
+7.4%5-Year
NEUTRAL$152
+57.6%Published batch insight
Multi-Brand Beauty Disruption Meets Structural Supply Chain Transformation
High consensus confirms rapid international retail door expansion and counter-cyclical trade-down dynamics drive multi-year revenue growth. However, sharp divergence persists regarding gross margin durability under Section 301 replacement tariffs, post-acquisition leverage digestion, and inevitable multiple compression toward mature consumer staple benchmarks.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Universal Investor (Polymath), Machiavelli (Insider), J.P. Morgan (Titan), Michael Burry (Vulture), Superintelligence (Anthropologist), Ray Dalio (Strategist), Elon Musk (Visionary), Warren Buffett (Value Purist), Sherlock Holmes (Whistleblower). Some archetypes run in multiple modes, resulting in 14 advisors total.
Full published thesis
Executive Summary
If you invested $10,000 in e.l.f. Beauty at the forecast anchor (2026-09-18): $15,756 in five years versus $13,892 for S&P 500 benchmark.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 97.33 | +0.92% | +0.92% | Initial European retail rollout metrics show strong consumer engagement, but the absence of prior tariff refund windfalls exposes underlying gross margin normalization, prompting modest valuation consolidation. |
| Q1 2027 | 97.91 | +0.60% | +1.53% | Holiday sales validate resilient trade-down demand across domestic mass retailers, while European door additions contribute incremental volume, offsetting elevated ocean freight and debt service expenses. |
| Q2 2027 | 101.32 | +3.48% | +5.06% | Fiscal 2027 annual reporting establishes a clean operational earnings baseline as contingent earnout distortions subside, driving initial institutional re-rating on visible free cash flow conversion. |
| Q3 2027 | 103.58 | +2.23% | +7.40% | Back-to-school cosmetic demand and expanding retail door productivity support mid-teens revenue growth, while ongoing supply chain shifts outside China mitigate Section 301 tariff friction. |
| Q4 2027 | 106.98 | +3.28% | +10.92% | Holiday promotional velocity across mass merchants and European specialty doors accelerates cash generation, enabling voluntary debt repayment and bolstering balance sheet flexibility. |
| Q1 2028 | 107.99 | +0.95% | +11.98% | Post-holiday channel inventory rebalancing creates mild seasonal wholesale deceleration, yet disciplined digital marketing spend and steady skincare replenishment preserve baseline operating profitability. |
| Q2 2028 | 111.97 | +3.68% | +16.10% | Fiscal 2028 disclosures demonstrate non-China manufacturing surpassing fifty percent, delivering sustainable gross margin stabilization above seventy-one percent and driving positive earnings estimate revisions. |
| Q3 2028 | 114.68 | +2.42% | +18.91% | International wholesale penetration reaches critical mass across European pharmacy and beauty chains, insulating consolidated revenues from mature domestic shelf saturation. |
| Q4 2028 | 118.18 | +3.06% | +22.55% | Peak seasonal volume across mass and prestige-adjacent assortments yields strong operating cash conversion, absorbing competitive promotional pressures from legacy beauty conglomerates. |
| Q1 2029 | 119.87 | +1.43% | +24.30% | Resolution of remaining acquisition earnout obligations removes structural accounting volatility, allowing reported GAAP earnings to converge cleanly with robust underlying cash flows. |
| Q2 2029 | 123.87 | +3.33% | +28.44% | Fiscal 2029 results highlight operating margin expansion toward thirteen percent, supported by international scale efficiencies and systematic de-leveraging of term debt. |
| Q3 2029 | 126.78 | +2.35% | +31.46% | Expanded skincare category penetration and premium lifestyle brand extensions enhance customer lifetime value, sustaining mid-teens top-line compounding despite broader consumer discretionary moderation. |
| Q4 2029 | 130.91 | +3.26% | +35.74% | Strong holiday sell-through in Western Europe and the Americas validates multi-brand platform durability, while disciplined inventory management minimizes markdown and promotional drag. |
| Q1 2030 | 132.98 | +1.58% | +37.89% | Successful refinancing or retirement of remaining acquisition credit facilities removes capital structure uncertainty, expanding strategic flexibility as policy interest rates stabilize. |
| Q2 2030 | 136.49 | +2.64% | +41.53% | Fiscal 2030 performance reflects transition into a mature global cash compounder, with management allocating surplus operational cash flows toward anti-dilutive share repurchases. |
| Q3 2030 | 139.78 | +2.41% | +44.94% | International operations contribute nearly thirty percent of total enterprise net sales, mitigating domestic retail cyclicality and reinforcing pricing power across global channels. |
| Q4 2030 | 144.08 | +3.08% | +49.40% | Holiday omnichannel execution delivers dependable cash generation, as multi-brand product bundling captures consumer mindshare without requiring margin-dilutive retail discounting. |
| Q1 2031 | 145.65 | +1.09% | +51.03% | Seasonal post-holiday volume patterns normalize smoothly, with high return on invested capital and controlled working capital cycles supporting predictable quarterly cash flow. |
| Q2 2031 | 148.99 | +2.29% | +54.49% | Fiscal 2031 reporting confirms durable operating margins above fourteen percent, proving the long-term economic viability of the diversified, asset-light beauty platform. |
| Q3 2031 | 151.95 | +1.99% | +57.56% | Terminal valuation aligns with normalized consumer staple compounder benchmarks, rewarding multi-year debt reduction, steady organic volume growth, and disciplined capital allocation. |
The institutional investment case resolves around the uncoupling of operational cash generation from headline GAAP accounting noise. Optical price-to-earnings distortions—stemming from contingent earnout revaluations and non-cash purchase amortization alongside a temporary $50 million tariff refund in Q1 FY2027—obscure trailing twelve-month free cash flow of $280 million. The base-case thesis projects consolidated net sales compounding in the low-to-mid teens as international specialty doors scale and masstige trade-down dynamics capture market share. Valuation sensitivity remains tied to gross margin defense against Section 301 replacement tariffs and term loan debt service.
Key insights
- International door productivity across European specialty retail provides high-margin operating leverage, diversifying cash generation away from domestic big-box merchant concentration.
- Shifting contract manufacturing past 50% non-China production permanently insulates unit economics from geopolitical tariff shocks, defending underlying gross margins above 71%.
- Rapid organic de-leveraging funded by asset-light cash conversion reduces refinancing risk, enabling capital reallocation toward share repurchases as earnout obligations expire.
The company looks much more expensive on paper than it is in reality because recent acquisitions created temporary accounting charges that depressed reported profits. Underneath those headlines, the business generates strong cash flow by selling high-quality, affordable cosmetics that budget-conscious shoppers prefer over expensive luxury brands. While trade tariffs and integration debt require careful management, expanding into overseas retail stores gives the company a reliable engine for long-term compounding growth.
Key insights
- Shoppers under inflation pressure actively switch from luxury cosmetics to high-performance, affordable beauty alternatives.
- Opening hundreds of new store locations across Europe expands brand reach and drives steady international sales.
- Low factory maintenance costs allow the company to use excess cash flow to pay down debt quickly.
Deep Dive
The prevailing market narrative treats the company as an overextended growth darling facing inevitable deceleration. Consensus sentiment anchors on compressed fiscal 2026 GAAP net margins, elevated balance sheet debt from recent brand acquisitions, and acute vulnerability to Chinese import tariffs. Investors widely assume that slowing domestic store traffic and intensifying copycat competition will permanently break the company's historical hyper-growth trajectory.